Literature DB >> 2155418

Gliosarcoma: a histologic and immunohistochemical reaffirmation.

J M Meis1, K L Ho, J S Nelson.   

Abstract

Seven cases of mixed glioblastoma multiforme (GBM) and sarcoma, or gliosarcoma (GS) and six cases of GBM with a prominent pilocytic or spindle cell component were studied with a panel of ten antibodies using the ABC method. All 13 cases were originally diagnosed as GS based on hematoxylin and eosin- (H&E) and reticulin-stained sections. In all GS, the glial component stained strongly for glial fibrillary acidic protein (GFAP), and most stained for S-100 protein, while the sarcomatous areas of GS did not stain for either of these antigens. This resulted in a characteristic, bimorphic marmorate staining pattern. In contrast, spindled GBM stained diffusely for GFAP and S-100 protein. Vimentin was detected in neoplastic glia of both GBM and GS and in the sarcomatous foci of GS. A spectrum of cytokeratins, Factor VIII, desmin and neurofilament were not detected in either GS or GBM. Actin, Leu 7 and alpha-1-antichymotrypsin were focally and inconsistently found in both GS and GBM. Perithelial spindle cell proliferations and intramural spindle cells within thick-walled vessels stained for GFAP, S-100 protein and/or vimentin. These studies confirm that GS is a true biphasic neoplasm that frequently cannot be distinguished from pilocytic or spindled GBM on routine histologic examination. Invasion of the dura, leptomeninges, and hyperplastic or hypertrophied blood vessels by malignant glial cells particularly confounds interpretation of H&E and reticulin stains. Immunohistochemical staining for GFAP complements the reticulin stain in confirming the presence of two cell populations in GS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155418

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  16 in total

1.  Gliofibroma: immunohistochemical analysis.

Authors:  R Schober; C Bayindir; A Canbolat; H Urich; W Wechsler
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Multi-focal gliosarcoma: a case report and review of the literature.

Authors:  E E Pakos; A C Goussia; V P Zina; E J Pitouli; P G Tsekeris
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

3.  Histogenesis of sarcomatous component of the gliosarcoma: an ultrastructural study.

Authors:  K L Ho
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  Genetic profile of gliosarcomas.

Authors:  R M Reis; D Könü-Lebleblicioglu; J M Lopes; P Kleihues; H Ohgaki
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

5.  Gliosarcomas: analysis of 11 cases do two subtypes exist?

Authors:  Maurizio Salvati; Emanuela Caroli; Antonino Raco; Felice Giangaspero; Roberto Delfini; Luigi Ferrante
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

Review 6.  Gliofibromas (including malignant forms), and gliosarcomas: a comparative study and review of the literature.

Authors:  M Cerda-Nicolas; J J Kepes
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Gliosarcoma: a study of four cases.

Authors:  Yildiz Güney; Ayse Hiçsönmez; Sercan Yilmaz; Yasemin Güzle Adas; Meltem Nalca Andrieu
Journal:  Rare Tumors       Date:  2010-06-30

8.  Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo.

Authors:  Ana C deCarvalho; Kevin Nelson; Nancy Lemke; Norman L Lehman; Ali S Arbab; Steven Kalkanis; Tom Mikkelsen
Journal:  Stem Cells       Date:  2010-02       Impact factor: 6.277

9.  Childhood's gliosarcomas: pathological and therapeutical considerations on three cases and critical review of the literature.

Authors:  Maurizio Salvati; Jacopo Lenzi; Christian Brogna; Alessandro Frati; Manolo Piccirilli; Felice Giangaspero; Antonino Raco
Journal:  Childs Nerv Syst       Date:  2006-03-16       Impact factor: 1.475

10.  Distribution of p53 protein expression in gliosarcomas: an immunohistochemical study.

Authors:  S Albrecht; J H Connelly; J M Bruner
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.